Clinical Trial Update: Evaluating Multiple Sclerosis Patients ShOWing A GEnomic Signature of Therapy Response

View source ↗

Summary

A completed clinical trial update from DxTerity Diagnostics evaluating a genomic signature associated with therapy response in patients with multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: DxTerity Diagnostics | Conditions: Multiple Sclerosis, MS | Status: COMPLETED